Medpace (NASDAQ:MEDP) Beats Expectations in Strong Q1 But Stock Drops [Yahoo! Finance]
Medpace Holdings, Inc. (MEDP)
Last medpace holdings, inc. earnings: 4/28 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.medpace.com
Company Research
Source: Yahoo! Finance
The company's full-year revenue guidance of $2.19 billion at the midpoint came in 1.9% above analysts' estimates. Its GAAP profit of $3.67 per share was 20.8% above analysts' consensus estimates. Is now the time to buy Medpace? Find out in our full research report Revenue: $558.6 million vs analyst estimates of $527.1 million (9.3% year-on-year growth, 6% beat) EPS (GAAP): $3.67 vs analyst estimates of $3.04 (20.8% beat) Adjusted EBITDA: $118.6 million vs analyst estimates of $118.1 million (21.2% margin, in line) The company lifted its revenue guidance for the full year to $2.19 billion at the midpoint from $2.16 billion, a 1.4% increase EPS (GAAP) guidance for the full year is $12.65 at the midpoint, beating analyst estimates by 2.8% EBITDA guidance for the full year is $477 million at the midpoint, in line with analyst expectations Operating Margin: 20.3%, in line with the same quarter last year Free Cash Flow Margin: 20.7%, down from 28.8% in the same quarter las
Show less
Read more
Impact Snapshot
Event Time:
MEDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEDP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEDP alerts
High impacting Medpace Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
MEDP
News
- Medpace (NASDAQ:MEDP) had its "underweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- How Medpace's Q3 2025 Surge and Buybacks Strategy Could Impact Medpace Holdings (MEDP) Investors [Yahoo! Finance]Yahoo! Finance
- 2 Profitable Stocks to Keep an Eye On and 1 We Find Risky [Yahoo! Finance]Yahoo! Finance
- Medpace (MEDP): Assessing Valuation After Revenue Growth, Buybacks and AI-Driven Clinical Trial Expansion [Yahoo! Finance]Yahoo! Finance
- Medpace Holdings, Inc. (MEDP): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
MEDP
Earnings
- 10/22/25 - Beat
MEDP
Sec Filings
- 12/9/25 - Form 4
- 12/4/25 - Form 4
- 12/4/25 - Form 4
- MEDP's page on the SEC website